Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics

Investigating HMGB1 as a potential serum biomarker for early diabetic nephropathy monitoring by quantitative proteomics

Summary: Current diagnostic methods for diabetic nephropathy (DN) lack precision, especially in early stages and monitoring progression. This study aims to find potential biomarkers for DN progression and evaluate their accuracy. Using serum samples from healthy controls (NC), diabetic patients (DM)...

Full description

Bibliographic Details
Main Authors: Rui Peng, Siyang Zuo, Xia Li, Yun Huang, Siyu Chen, Xue Zou, Hehua Long, Min Chen, Yuan Yang, Huixiong Yuan, Qingqing Zhao, Bing Guo, Lirong Liu
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:iScience
Subjects:
Health sciences
Medicine
Medical specialty
Internal medicine
Endocrinology
Biological sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224000555

Internet

http://www.sciencedirect.com/science/article/pii/S2589004224000555

Similar Items